We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (383)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
758 result(s) found, displaying 501 to 525
-
Corporate reports
-
TGA laboratory testing reportsTGA Laboratories has released a report detailing testing of alkyl nitrite products
-
Scheduling decisions (final)Delegate-only scheduling final decisions are now available
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in November 2018
-
Scheduling decisions (final)Final decisions and reasons for NCEs and medicines and chemicals referred to the November 2018 scheduling meetings (ACMS #25, ACCS #23 and Joint ACMS-ACCS #20).
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 28 March 2019
-
Meeting statementsCommunique from the second meeting of the TGACC
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Meeting statementsThe Public Statement for the Generic Medicines Working Group face-to-face meeting in Canberra, October 2018
-
Corporate reportsThe Action Plan will further improve Australia’s medical device regulatory system and place patient safety first
-
Corporate reportsThe 2018 Half Yearly Performance Snapshot is now available
-
Meeting statementsPublic statement for the Generic Medicines Working Group face-to-face meeting in Switzerland, May 2018
-
Corporate reportsStatistics from inspections conducted from 1 September 2017 to 31 December 2018
-
Meeting statementsCommunique summarising outcomes of the alkyl nitrites public meetings in Sydney and Melbourne
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
TGA laboratory testing reportsThe TGA has tested a range of human insulin products and all met the applicable quality standards
-
Corporate reports
-
Meeting statementsACM 12 meeting statement has been published
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 7 March 2019
-
Corporate reportsAlkyl nitrites public meeting questions and answers are now available
-
Scheduling submissionsThe TGA would like to thank respondents who provided submissions in response to the November 2018 public consultation paper
-
Meeting statementsCommunique from the first meeting of the TGACC
-
Meeting statementsACCM meeting statement for 16 November 2018 published
-
Corporate reports
-
Corporate reportsThe TGA conducted a survey of Australian adults in June and July 2018